Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-05-11 Sale | 2023-05-15 4:37 pm | 10x Genomics Inc. | TXG | Mammen Mathai Director | 33,000 | $52.82 | $1,743,086 | 169,745 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-06-11 Option Award | 2024-06-13 4:22 pm | N/A N/A | 10x Genomics Inc. | TXG | Mammen Mathai Director | 8,649 | $0 | 180,259 (Direct) | View |
| 2023-06-14 Option Award | 2023-06-16 5:40 pm | N/A 2033-06-14 | 10x Genomics Inc. | TXG | Mammen Mathai Director | 6,526 | $0 | 176,271 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 4:37 pm | N/A N/A | 10x Genomics Inc. | TXG | Mammen Mathai Director | 200,000 | $1.16 | 169,745 (Direct) | View |
| 2023-05-11 Exercise | 2023-05-15 4:37 pm | N/A 2027-06-12 | 10x Genomics Inc. | TXG | Mammen Mathai Director | 200,000 | $0 | 169,745 (Direct) | View |
| 2022-06-15 Option Award | 2022-06-17 5:14 pm | N/A 2031-06-15 | 10x Genomics Inc. | TXG | Mammen Mathai Director | 7,420 | $0 | 8,045 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-17 06:00 am | 2025-02-14 2032-02-14 | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 38,736 | $165.89 | 85,329 (Direct) | View |
| 2022-02-15 Tax Withholding | 2022-02-17 06:00 am | N/A N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 3,366 | $165.89 | 85,329 (Direct) | View |
| 2022-02-15 Exercise | 2022-02-17 06:00 am | 2022-02-11 N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 7,740 | $0 | 85,329 (Direct) | View |
| 2022-02-14 Option Award | 2022-02-17 06:00 am | 2025-02-14 N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 3,922 | $0 | 85,329 (Direct) | View |
| 2022-02-14 Exercise | 2022-02-15 8:03 pm | 2022-02-11 N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 7,418 | $0 | 37,560 (Direct) | View |
| 2022-02-14 Tax Withholding | 2022-02-15 8:03 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 2,335 | $168.85 | 37,560 (Direct) | View |
Ownership | 2022-01-13 4:43 pm | N/A N/A | JOHNSON & JOHNSON | JNJ | Mammen Mathai EVP, Pharm, R&D | 0 | $0 | 250,624 (Direct) | View |
| 2021-06-11 Option Award | 2021-06-15 5:50 pm | N/A 2031-06-11 | 10x Genomics Inc. | TXG | Mammen Mathai Director | 2,188 | $0 | 2,188 (Direct) | View |
| 2020-06-15 Option Award | 2020-06-17 4:29 pm | N/A 2030-06-15 | 10x Genomics Inc. | TXG | Mammen Mathai Director | 4,432 | $0 | 4,432 (Direct) | View |